| n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes 2011 · ALA · Adults aged 60–80 with diabetes and a previous myocardial infarction | 2 g | 1217 days | 258 |
| Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4 1997 · mustard oil (group B) · Patients with suspected acute myocardial infarction; age and sex not stated | 2.9 g | 1 year | 120 |
| Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction 2012 · ALA · Adults with a history of myocardial infarction; statin users and non-users | 2 g | — | — |
| n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes 2011 · EPA-DHA plus ALA · Adults aged 60–80 with diabetes and a previous myocardial infarction | 2 g | 1217 days | 245 |
| Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction 2012 · EPA-DHA plus ALA · Adults with a history of myocardial infarction; statin users and non-users | 2 g | — | — |
| Essential fatty acids: the effects of dietary supplementation among children with recurrent respiratory infections 1996 · essential fatty acid supplementation · Children aged 36–49 months with recurrent respiratory infections | 855 mg | 120 days | — |
| Consumption of alpha-Linolenic Acid-enriched Diacylglycerol Reduces Visceral Fat Area in Overweight and Obese Subjects: a Randomized, Double-blind Controlled, Parallel-group Designed Trial 2016 · ALA-DAG group · Overweight and obese subjects | 2.5 g | 12 weeks | 88 |
| The effect of a 1-year multiple micronutrient or n-3 fatty acid fortified food intervention on morbidity in Indian school children 2012 · High micronutrients + low n-3 fatty acids · Children aged 6–10 years in India | 140 mg | 1 year | — |
| The effect of a 1-year multiple micronutrient or n-3 fatty acid fortified food intervention on morbidity in Indian school children 2012 · Low micronutrients + low n-3 fatty acids · Children aged 6–10 years in India | 140 mg | 1 year | — |
| Effects of Varied Omega-3 Fatty Acid Supplementation on Postpartum Mental Health and the Association between Prenatal Erythrocyte Omega-3 Fatty Acid Levels and Postpartum Mental Health 2023 · perilla oil group · Healthy primiparous pregnant women aged 19–45 years | 2.4 g | 12 weeks | 126 |
| The effects of concurrent alpha-linolenic acid, L-carnitine supplementation on clinical symptoms, mental health, and quality of life in women with migraine: a randomized, triple-blind, placebo-controlled trial 2025 · Alpha-linolenic plus L-carnitine group · Women aged 20–50 years with migraine | 350 mg | 12 weeks | 40 |
| Supplementation with Flaxseed Oil Rich in Alpha-Linolenic Acid Improves Verbal Fluency in Healthy Older Adults 2023 · ALA group · Healthy right-handed men and women aged 65–80 years without cognitive impairment | 2.2 g | 12 weeks | 30 |
| Effects of diacylglycerol-enriched alpha-linolenic acid oil on skin properties in mild skin discomfort: a randomized, double-blind, placebo-controlled study 2026 · ALA-DAG group · Men and women aged 20–59 with mild subjective skin discomfort and occasional allergy-like symptoms, without a clinical diagnosis of allergic disease | 900 mg | 8 weeks | 30 |
| Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals 2020 · Flaxseed oil · Overweight and obese adults aged 60 ± 8 years with high-normal blood pressure or mild (stage I) hypertension | 4.7 g | 12 weeks | 29 |
| Omega-3 polyunsaturated fatty acids-enriched hen eggs consumption enhances microvascular reactivity in young healthy individuals 2018 · OMEGA-3 group · Young healthy individuals; age range and sex not specified | 501 mg | 3 weeks | 20 |
| Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support 1996 · study formula · 10 men with symptomatic HIV infection on stable medication regimens | 1.8 g | 120 days | 10 |
| The effect of a 1-year multiple micronutrient or n-3 fatty acid fortified food intervention on morbidity in Indian school children 2012 · High micronutrients + high n-3 fatty acids · Children aged 6–10 years in India | 900 mg | 1 year | — |
| The effect of a 1-year multiple micronutrient or n-3 fatty acid fortified food intervention on morbidity in Indian school children 2012 · Low micronutrients + high n-3 fatty acids · Children aged 6–10 years in India | 900 mg | 1 year | — |
| Perilla seed oil in combination with nobiletin-rich ponkan powder enhances cognitive function in healthy elderly Japanese individuals: a possible supplement for brain health in the elderly 2022 · PO group · Healthy elderly Japanese individuals; age and sex not specified | 880 mg | 1 year | — |
| Perilla seed oil in combination with nobiletin-rich ponkan powder enhances cognitive function in healthy elderly Japanese individuals: a possible supplement for brain health in the elderly 2022 · PO + ponkan powder (POPP) group · Healthy elderly Japanese individuals; age and sex not specified | 880 mg | 1 year | — |
| Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans 1990 · alpha-linolenic acid (linseed oil) group · Men with mild hypercholesterolemia; age not reported | 9 g | 6 weeks | — |
| Supplementation of α-linolenic acid improves serum adiponectin levels and insulin sensitivity in patients with type 2 diabetes 2015 · ALA group · Adults with type 2 diabetes mellitus; age and sex not specified | 3 g | 60 days | — |
| Camelina Sativa Oil, but not Fatty Fish or Lean Fish, Improves Serum Lipid Profile in Subjects with Impaired Glucose Metabolism-A Randomized Controlled Trial 2018 · CSO group · Adults aged 43–72 years with impaired fasting glucose and BMI 25–36 kg/m² | 10 g | 12 weeks | — |
| Effect of alpha-linolenic acid in combination with the flavonol quercetin on markers of cardiovascular disease risk in healthy, non-obese adults: A randomized, double-blinded placebo-controlled crossover trial 2019 · ALA plus placebo · Healthy, non-obese men and women; mean age 24.6 years | 3.6 g | 8 weeks | — |
| Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial 2025 · intervention group · Chinese adults with mild cognitive impairment; mean age 67.95 years; 70 male and 120 female | 288 mg | 1 year | 95 |
| Cognitive and Mood Effects of a Nutrient Enriched Breakfast Bar in Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled, Parallel Groups Study 2017 · nutrient enriched · Healthy adults aged 21–40 years | 1.4 g | 8 weeks | 48 |
| Effect of alpha-linolenic acid in combination with the flavonol quercetin on markers of cardiovascular disease risk in healthy, non-obese adults: A randomized, double-blinded placebo-controlled crossover trial 2019 · ALA plus quercetin · Healthy, non-obese men and women; mean age 24.6 years | 3.6 g | 8 weeks | — |
| The Effect of Crackers Enriched with Camelina Sativa Oil on Omega-3 Serum Fatty Acid Composition in Older Adults: A Randomized Placebo-Controlled Pilot Trial 2023 · Camelina group · Free-living adults aged 64–80 years (eligible participants were aged ≥65); older adults without the specified exclusion conditions | 2.6 g | 12 weeks | 34 |
| Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans 2006 · Flaxseed oil group · Predominantly African-American participants with chronic illness; age and sex not specified | 3 g | 12 weeks | 31 |
| Increased dietary α-linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination of data from a randomised, placebo-controlled, parallel study 2014 · Control group (standard high-linoleic-acid, low-ALA margarine) · Healthy men and women aged 25–72 years | 1.5 g | 26 weeks | 30 |
| Increased dietary α-linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination of data from a randomised, placebo-controlled, parallel study 2014 · High-ALA group (ALA-enriched margarine) · Healthy men and women aged 25–72 years | 9.5 g | 26 weeks | 29 |
| Bioavailability of Dietary Omega-3 Fatty Acids Added to a Variety of Sausages in Healthy Individuals 2017 · placebo group · Healthy adults aged 20–60 years with Omega-3 Index below 5% | 257 mg | 8 weeks | 22 |
| Modification of Docosahexaenoic Acid Composition of Milk from Nursing Women Who Received Alpha Linolenic Acid from Chia Oil during Gestation and Nursing 2015 · Chia group · Pregnant women aged 22–35 years, from the sixth month of pregnancy through six months of nursing; no chronic disease or underweight | 16 mL | 274 days | 19 |
| The effect of dietary trans alpha-linolenic acid on plasma lipids and platelet fatty acid composition: the TransLinE study 2000 · High trans diet · Male volunteers; age and health status not reported | 1.41 g | 6 weeks | — |
| The effect of dietary trans alpha-linolenic acid on plasma lipids and platelet fatty acid composition: the TransLinE study 2000 · Low trans diet · Male volunteers; age and health status not reported | 60 mg | 6 weeks | — |
| Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects 2003 · 3.5 g ALNA/d · Healthy males aged 18–39 years | 3.5 g | 12 weeks | — |
| Effects of the flavonol quercetin and α-linolenic acid on n-3 PUFA status in metabolically healthy men and women: a randomised, double-blinded, placebo-controlled, crossover trial 2017 · ALA+placebo · Metabolically healthy adult men and women | 3.3 g | 8 weeks | — |
| Systemic inflammation in morbidly obese subjects: response to oral supplementation with alpha-linolenic acid 2007 · Flaxseed flour · Morbidly obese outpatient adults; mean age 40.8 years, 83.3% female | 5 g | 2 weeks | 24 |
| The effect of different sources of fish and camelina sativa oil on immune cell and adipose tissue mRNA expression in subjects with abnormal fasting glucose metabolism: a randomized controlled trial 2019 · CSO group · Adults aged 40–75 with impaired fasting glucose, BMI 25–36 kg/m², and no chronic disease | 27 g | 12 weeks | 18 |
| Consumption of alpha-linolenic acid-enriched diacylglycerol induces increase in dietary fat oxidation compared with alpha-linolenic acid-enriched triacylglycerol: A randomized, double-blind trial 2017 · ALA-DAG · Men and women with normal weight or moderate obesity; mean BMI 25.7 ± 2.0 kg/m² | 2.5 g | 4 weeks | 17 |
| Consumption of alpha-linolenic acid-enriched diacylglycerol induces increase in dietary fat oxidation compared with alpha-linolenic acid-enriched triacylglycerol: A randomized, double-blind trial 2017 · ALA-TAG · Men and women with normal weight or moderate obesity; mean BMI 25.7 ± 2.0 kg/m² | 2.5 g | 4 weeks | 17 |
| Effects of dietary n-3 polyunsaturated fatty acids from plant and marine origin on platelet aggregation in healthy elderly subjects 1999 · alpha-linolenic acid diet, elderly subjects · Adults older than 60 years, healthy elderly subjects | 6.8 g | 6 weeks | 14 |
| α-Linolenic acid increases the G0/G1 switch gene 2 mRNA expression in peripheral blood mononuclear cells from obese patients: a pilot study 2016 · ALA-treated group · Obese adults with BMI greater than 30.0 kg/m²; 6 women and 8 men | 4 g | 12 weeks | 14 |
| Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects 2006 · ALA-rich diet · Healthy mildly hypercholesterolemic adults aged 60–78 years, 14 men and 23 women across the study | 6.8 g | 6 weeks | 13 |
| Effect of altered dietary n-3 fatty acid intake upon plasma lipid fatty acid composition, conversion of [13C]alpha-linolenic acid to longer-chain fatty acids and partitioning towards beta-oxidation in older men 2003 · increased ALNA intake · Healthy men, mean age 52 (SD 12) years | 10 g | 8 weeks | 4 |
| Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y 2001 · ALA group · Healthy adults aged 55–75 years | 2 g | 12 weeks | — |
| Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study 2001 · High-trans diet · Healthy European men | 1.41 g | 6 weeks | — |
| Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans 2001 · ALNA group · Healthy adults aged 55–75 years | 2 g | 12 weeks | — |
| Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults 2001 · ALNA · Healthy adults aged 55–75 years | 2 g | 12 weeks | — |
| Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects 2003 · 4.5 g ALA/d · Moderately hyperlipidemic subjects; age and sex not specified | 4.5 g | 26 weeks | — |
| Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects 2003 · 9.5 g ALA/d · Moderately hyperlipidemic subjects; age and sex not specified | 9.5 g | 26 weeks | — |
| Alpha-linolenic acid supplementation and resistance training in older adults 2009 · ALA in flax oil · Older adults, mean age 65.4 years; men and women participating in resistance training | 14 g | 12 weeks | — |
| Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans 2009 · ALA group · Healthy normolipidemic men and women aged 19–43 years | 4.4 g | 6 weeks | — |
| n-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants 1990 · alpha-linolenic acid diet · Normotensive and mildly hypercholesterolemic men | 9.2 g | 6 weeks | — |
| Margarines fortified with α-linolenic acid, eicosapentaenoic acid, or docosahexaenoic acid alter the fatty acid composition of erythrocytes but do not affect the antioxidant status of healthy adults 2012 · ALA margarine group · Healthy men and women; age range and sex-specific numbers not reported | 4.4 g | 6 weeks | — |
| Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial 2014 · α-linolenic acid group · Patients aged 60–80 years with a history of myocardial infarction; 81% were men. | 1.99 g | 1200 days | — |
| Benefits of foods supplemented with vegetable oils rich in α-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail 2015 · α-linolenic acid (ALA) group · Hypertriglyceridemic subjects with triglycerides ≥ 1.5 mmol/L; age and sex not stated | 7 g | 10 weeks | — |
| Docosahexaenoic acid-enriched canola oil increases adiponectin concentrations: a randomized crossover controlled intervention trial 2015 · FlaxSaff (flax/safflower oil blend) · Adult men and women with abdominal obesity and at least one other criterion for metabolic syndrome | 60 g | 4 weeks | — |
| Alpha-Linolenic Acid-Enriched Diacylglycerol Oil Suppresses the Postprandial Serum Triglyceride Level-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study 2016 · 1.25-g treatment · People with normal or moderately high fasting serum triglyceride levels | 1.25 g | 1 day | — |
| Alpha-Linolenic Acid-Enriched Diacylglycerol Oil Suppresses the Postprandial Serum Triglyceride Level-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study 2016 · 2.50-g treatment · People with normal or moderately high fasting serum triglyceride levels | 2.5 g | 1 day | — |
| The effect of intakes of fish and Camelina sativa oil on atherogenic and anti-atherogenic functions of LDL and HDL particles: A randomized controlled trial 2019 · CSO · Volunteers with impaired glucose metabolism | 10 g | 12 weeks | — |
| EPA+DHA, but not ALA, Improved Lipids and Inflammation Status in Hypercholesterolemic Adults: A Randomized, Double-Blind, Placebo-Controlled Trial 2019 · 4.2 g/d ALA · Adults with hypercholesterolemia; age range and sex not specified | 4.2 g | 12 weeks | — |
| EPA+DHA, but not ALA, Improved Lipids and Inflammation Status in Hypercholesterolemic Adults: A Randomized, Double-Blind, Placebo-Controlled Trial 2019 · 7.2 g/d ALA · Adults with hypercholesterolemia; age range and sex not specified | 7.2 g | 12 weeks | — |
| Camelina sativa Oil, Fatty Fish, and Lean Fish Do Not Markedly Affect Urinary Prostanoids in Subjects with Impaired Glucose Metabolism 2019 · Camelina sativa oil (CSO) · Adults aged 43–72 years with impaired glucose metabolism | 10 g | 12 weeks | — |
| Time Course and Sex Effects of α-Linolenic Acid-Rich and DHA-Rich Supplements on Human Plasma Oxylipins: A Randomized Double-Blind Crossover Trial 2021 · ALA-rich supplement · Healthy men and women aged 19–34 years with BMI 18–28 kg/m² | 4 g | 4 weeks | — |
| Oils Rich in α-Linolenic Acid or Docosahexaenoic Acid Have Distinct Effects on Plasma Oxylipin and Adiponectin Concentrations and on Monocyte Bioenergetics in Women with Obesity 2021 · ALA-rich flaxseed oil · Women aged 20–51 with obesity (BMI 30–51 kg/m²) | 4 g | 4 weeks | — |
| Lipidomic changes of LDL after consumption of Camelina sativa oil, fatty fish and lean fish in subjects with impaired glucose metabolism-A randomized controlled trial 2021 · CSO group · Adult women and men with impaired glucose tolerance; age range not reported | 10 g | 12 weeks | — |
| Dietary n-3 alpha-linolenic and n-6 linoleic acids modestly lower serum lipoprotein(a) concentration but differentially influence other atherogenic lipoprotein traits: A randomized trial 2024 · ALA diet · Men homozygous for FADS1 rs174550 TT or CC genotype | 30 mL | 8 weeks | — |
| The Effects of α-Linolenic Acid Intake on Skin and Blood Vessel Health and Subjective Fatigue in Middle-Aged Japanese Females: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparative Trial 2025 · 0.97 g/d ALA group · Japanese females aged 45–65 years | 970 mg | 12 weeks | — |
| The Effects of α-Linolenic Acid Intake on Skin and Blood Vessel Health and Subjective Fatigue in Middle-Aged Japanese Females: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparative Trial 2025 · 1.36 g/d ALA group · Japanese females aged 45–65 years | 1.36 g | 12 weeks | — |
| The Effects of α-Linolenic Acid Intake on Skin and Blood Vessel Health and Subjective Fatigue in Middle-Aged Japanese Females: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparative Trial 2025 · 2.13 g/d ALA group · Japanese females aged 45–65 years | 2.13 g | 12 weeks | — |
| Consumption of echium oil increases EPA and DPA in blood fractions more efficiently compared to linseed oil in humans 2016 · Echium oil (EO) · Adults aged 20–69 years, women and men, including normal-weight and overweight participants; no chronic disease reported | 5 g | 8 weeks | 60 |
| Consumption of echium oil increases EPA and DPA in blood fractions more efficiently compared to linseed oil in humans 2016 · Linseed oil mixture (LO) · Adults aged 20–69 years, women and men, including normal-weight and overweight participants; no chronic disease reported | 5 g | 8 weeks | 60 |
| Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome 2004 · ALA+LA supplementation · Pregnant women from week 14 of gestation until delivery | 2.8 g | — | 29 |
| Bioavailability of Dietary Omega-3 Fatty Acids Added to a Variety of Sausages in Healthy Individuals 2017 · verum group · Healthy adults aged 20–60 years with Omega-3 Index below 5% | 240 mg | 8 weeks | 22 |
| Effects of dietary alpha-linolenic acid on the conversion and oxidation of 13C-alpha-linolenic acid 2000 · alpha-linolenic acid diet · Healthy human volunteers; age and sex not reported | 8.3 g | 6 weeks | 7 |
| Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids 2006 · flaxseed oil · 20 study participants; age, sex, and health condition not specified | 3.51 g | 8 weeks | — |
| Effects of a lipid-based nutrient supplement during pregnancy and lactation on maternal plasma fatty acid status and lipid profile: Results of two randomized controlled trials 2017 · small-quantity lipid-based nutrient supplement (SQ-LNS) · Pregnant women in Ghana and Malawi; Ghana participants were at least 18 years old, and Malawi participants were at least 15 years old | 590 mg | 56 weeks | — |
| Effects of the flavonol quercetin and α-linolenic acid on n-3 PUFA status in metabolically healthy men and women: a randomised, double-blinded, placebo-controlled, crossover trial 2017 · ALA+quercetin · Metabolically healthy adult men and women | 3.3 g | 8 weeks | — |
| Dietary oils and FADS1-FADS2 genetic variants modulate [13C]α-linolenic acid metabolism and plasma fatty acid composition 2013 · FXCO diet · Hyperlipidemic subjects; age and sex not specified | 20.6 g | 4 weeks | 36 |
| Dietary oils and FADS1-FADS2 genetic variants modulate [13C]α-linolenic acid metabolism and plasma fatty acid composition 2013 · HOCO diet · Hyperlipidemic subjects; age and sex not specified | 2.4 g | 4 weeks | 36 |
| The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial 2017 · omega-3 fatty acids and vitamin E co-supplementation · Women aged 18–40 years with polycystic ovary syndrome | 400 mg | 12 weeks | 34 |
| The Effects of Omega-3 Fatty Acids Supplementation on Gene Expression Involved in the Insulin and Lipid Signaling Pathway in Patients with Polycystic Ovary Syndrome 2017 · omega-3 fatty acids from flaxseed oil · Women aged 18–40 diagnosed with polycystic ovary syndrome according to the Rotterdam criteria | 800 mg | 12 weeks | 30 |
| Flaxseed Oil Supplementation Improve Gene Expression Levels of PPAR-γ, LP(a), IL-1 and TNF-α in Type 2 Diabetic Patients with Coronary Heart Disease 2017 · Flaxseed oil group · Overweight adults with type 2 diabetes and coronary heart disease; sex and age range not reported | 800 mg | 12 weeks | 30 |
| The effects of n-3 fatty acids from flaxseed oil on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomised, double-blind, placebo-controlled trial 2020 · n-3 fatty acids from flaxseed oil · Women with gestational diabetes mellitus | 800 mg | 6 weeks | 30 |
| Double blind randomized clinical trial controlled by placebo with an alpha linoleic acid and prebiotic enriched cookie on risk cardiovascular factor in obese patients 2011 · Group I (inulin, FOS and ALA enriched cookie) · Obese patients; age and sex not specified | 3.2 g | 30 days | 15 |
| Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes 2010 · milled flaxseed (FXS) · Adults with well-controlled type 2 diabetes; mean age 52.4 years; men and women | 7.4 g | 12 weeks | 13 |
| Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes 2010 · flaxseed oil (FXO) · Adults with well-controlled type 2 diabetes; mean age 52.4 years; men and women | 7.4 g | 12 weeks | 12 |
| Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults 2007 · group A (anti-inflammatory blend) · healthy adult volunteers | 240 mg | 2 weeks | — |
| Lignan content of the flaxseed influences its biological effects in healthy men and women 2013 · High-lignan FLX bar · Healthy men and women, mean age 54±7 years | 3 g | 6 weeks | — |
| Lignan content of the flaxseed influences its biological effects in healthy men and women 2013 · Regular FLX bar · Healthy men and women, mean age 54±7 years | 3 g | 6 weeks | — |
| Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial 2014 · eicosapentaenoic acid-docosahexaenoic acid plus α-linolenic acid group · Patients aged 60–80 years with a history of myocardial infarction; 81% were men. | 1.99 g | 1200 days | — |
| alpha-Linolenic acid- and docosahexaenoic acid-enriched eggs from hens fed flaxseed: influence on blood lipids and platelet phospholipid fatty acids in humans 1995 · Eggs from hens fed diets containing 10% ground flaxseed · Male volunteers; age and health status not specified | 1.04 g | 2 weeks | — |
| Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial 2024 · intervention group · Adults aged 18–70 with obesity and dyslipidemia | 1 g | 90 days | 105 |